Search

everythinglearnresearchcommunity

for

Search:↓

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Children with alopecia areata often have low vitamin D, especially if they have darker skin, it's not summer, or they're not White.

A man with total hair loss developed blackhead-like spots on his scalp, possibly because no hair was present to help drain oils.

Excimer light therapy is more effective than low level laser therapy for treating alopecia areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Standard intralesional corticosteroids are the best treatment for patchy alopecia areata.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

PRP is a safe and effective treatment for hair growth in alopecia areata.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Topical sensitizers have mixed success in treating alopecia areata.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

An elderly man's hair grew back after a treatment that transferred healthy gut bacteria.

Black and Hispanic women are more likely to have alopecia areata than white women.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.